Limited-Time September Offer: Try 7 Days for Free

Homology Medicines (0T6G.L) Stock Price

$1.87 1.2%

Sign up
to add to portfolio

AI Score

  • Alternative

    8
  • Fundamental

    1
  • Technical

    4

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Homology Medicines, AI stock picks, stock alerts and much more.

Sign up

0T6G.L AI Stock Analysis

AI stock analysis for 0T6G.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Homology Medicines (0T6G.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Homology Medicines (0T6G.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Homology Medicines (0T6G.L), currently trading at $1.87, will... Sign up to access price prediction.

About 0T6G.L

LSE
  • Homology Medicines, Inc.

  • Symbol

    0T6G.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    22.8M

0T6G.L Alternative Data

Web Traffic

Homology Medicines receives an estimated 119 monthly visitors to homologymedicines.com.

  • Web Traffic

    119

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Twitter Followers

Homology Medicines has 217 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.9% over the last month.

  • Twitter Followers

    217

  • Daily Change

    0%

  • 1 Month Change

    1.9%

  • 3 Month Change

    6.4%

  • YoY Change

    6.4%

News Mentions

Homology Medicines was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Homology Medicines has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

0T6G.L Financials

0T6G.L Key Metrics
  • Total Revenue

    $0

  • Net Income

    -$17M

  • Earnings per Share

    -$1.42

  • Free cash flow

    -$22.2M

  • EBITDA

    -$17.8M

  • EBITDA Ratio

    0

  • Total Assets

    $92.3M

0T6G.L 2-year Revenue & Income
0T6G.L 2-year Free Cash Flow

0T6G.L Technicals

0T6G.L SMA
0T6G.L RSI

FAQ

What's the current price of Homology Medicines (0T6G.L) Stock?
The price of an Homology Medicines (0T6G.L) share is $1.87.

What's the market cap of Homology Medicines?
The current market cap of Homology Medicines is 22.8M.

What are some stocks similar to Homology Medicines (0T6G.L) that investors often compare it to?
Homology Medicines (0T6G.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.

What is the forecast for Homology Medicines' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Homology Medicines' stock price to be around $1.81 in 2026. Starting from the current price of $1.87, this represents a 3% change in price, indicating a neutral outlook for the stock.

How to buy Homology Medicines (0T6G.L) Stock?
Homology Medicines stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Homology Medicines shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.